SCHEMBL10002240

SCHEMBL10002240

CCO[Si](C)(C)CCCNC(=O)OCCCO

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACHE P22303 14/20 0.56
EPHX2 P34913 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8191086 0.86 ACHE (0.58) ACHEEPHX2
SCHEMBL24997030 0.82 ACHE (0.48) ACHEEPHX2
SCHEMBL12547756 0.81 ACHE (0.49) ACHE
SCHEMBL14553051 0.80 ACHE (0.47) ACHE
SCHEMBL24732289 0.80 ACHE (0.47) ACHE
SCHEMBL10018607 0.79 ACHE (0.41) ACHE
SCHEMBL5248874 0.79 ACHE (0.86) ACHEEPHX2
SCHEMBL10002243 0.78 NAAA (0.45)
SCHEMBL18198077 0.78 ACHE (0.65) ACHE
SCHEMBL13216896 0.78 ACHE (0.42) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8450513-B2 Silane compositions for polyester nanocomposites E I DU PONT DE NEMOURS AND COMPANY (US) 2013-05-28 US disclosed
US-8383716-B2 Polyester nanocomposites E I DU PONT DE NEMOURS AND COMPANY (US) 2013-02-26 US disclosed
US-20120029148-A1 POLYESTER NANOCOMPOSITES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-02-02 US disclosed
US-20120029222-A1 SURFACE-MODIFIED PARTICLES FOR POLYESTER NANOCOMPOSITES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-02-02 US disclosed
US-20120029221-A1 SILANE COMPOSITIONS FOR POLYESTER NANOCOMPOSITES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029222-A1 SURFACE-MODIFIED PARTICLES FOR POLYESTER NANOCOMPOSITES STT3A, ITGA2, STT3B ACHE 2797/4885EPHX2 2036/4885
US-20120029221-A1 SILANE COMPOSITIONS FOR POLYESTER NANOCOMPOSITES STT3A, ITGA2, ILK ACHE 4146/4885EPHX2 2754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.